Richard Peck
Oprichter bij Cellestia Biotech AG
Oorsprong van het eerstegraads netwerk van Richard Peck
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Cellestia Biotech AG
Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Richard Peck via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Aurealis Oy
Aurealis Oy BiotechnologyHealth Technology Aurealis Oy operates as a biopharmaceutical company which develops treatment method that improves life for chronic inflammation and cancer sufferers. It develops a proprietary technology, which utilizes genetically modulated probiotics that deliver a variety of therapeutic proteins to diseased tissue, thus modulating local immune system and enabling healing. The company was founded by Dirk Weber and Thomas Wirth in 2010 and is headquartered in Kuopio, Finland. | Biotechnology | Director/Board Member Founder | |
University of St. Gallen | College/University | Masters Business Admin | |
Kinarus AG
Kinarus AG Pharmaceuticals: MajorHealth Technology Part of Kinarus Therapeutics Holding AG, Kinarus AG is a Swiss clinical stage pharmaceutical company that focuses on novel treatments to patients suffering from viral, respiratory and ophthalmic diseases. The company is based in Basel, Switzerland. The company was founded in 2017 by Alexander Bausch, Roger Meier. Alexander Bausch has been the CEO since 2017. Kinarus was acquired by Perfect Holding SA on June 03, 2022. | Pharmaceuticals: Major | Director/Board Member | |
Artidis AG
Artidis AG Medical SpecialtiesHealth Technology Artidis AG develops nano mechanical biomarkers for rapid cancer diagnostics. The private company is based in Basel, Switzerland. The Swiss company was founded by Marija Plodinec, Marko Loparic, Philipp Oertle, Tobias Appenzeller. Marija Plodinec has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
Helvecura Genossenschaft | Director/Board Member | ||
Hänseler AG
Hänseler AG Pharmaceuticals: MajorHealth Technology Hänseler AG manufactures and wholesales pharmaceutical products. It offers liquid, semi-solid and solid drug forms and drug substances in conformity with GMP. The firm manufactures galenical, which includes liquid, semi-solid and solid drug forms; and liquid extracts and tinctures. The company was founded by Edwin Hanseler in 1975 and is headquartered in Herisau, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Aurealis Pharma AG
Aurealis Pharma AG Miscellaneous Commercial ServicesCommercial Services Part of Aurealis Oy, Aurealis Pharma AG is a Swiss company that provides scientific research and development services. The company is based in Basel, Switzerland. The company was founded by Juha Matti Yrjänheikki. | Miscellaneous Commercial Services | Director/Board Member | |
University of Zurich | College/University | Doctorate Degree | |
GENENTA SCIENCE S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Krebsforschung Schweiz | Director/Board Member | ||
Swiss Cancer Foundation | Director/Board Member | ||
Vital Solutions Swiss AG | Chairman | ||
Strekin AG
Strekin AG BiotechnologyHealth Technology Strekin AG is a Swiss pharmaceutical company that develops pharmaceuticals, therapeutics, and vaccines. The private company was founded in 2014 and is based in Basel, Switzerland. | Biotechnology | Director/Board Member | |
Nexilis AG
Nexilis AG BiotechnologyHealth Technology Nexilis AG is a Swiss medtech company that specializes in providing cost-effective fixation enhancement for any bone screw. The private company's flagship product is the Immediate Stabilisation System (ISS), which is an implantable polymer sleeve that is moulded around the pedicle screw using ultrasonic energy. Nexilis has a culture built around innovative science, precision, and quality, and has engaged in collaborations with renowned institutions to create safe and easy-to-implement solutions for surgeons. The company was founded by Martin Horst and the CEO is Leanna Caron. | Biotechnology | Director/Board Member | |
Just Finance AG | Director/Board Member | ||
Tethis SpA
Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Director/Board Member | |
Hthc High Tech Home Care AG | Chairman | ||
Novartis Norge AS
Novartis Norge AS Miscellaneous Commercial ServicesCommercial Services Novartis Norge AS develops, markets, and trades pharmaceuticals. It offers ophthalmic and generic products. The company is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Chairman | |
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Aurora Tt SRL | Founder | ||
Geleven SRL | Chief Executive Officer | ||
Sharper Italia | Chief Tech/Sci/R&D Officer | ||
Aurora Science Srl
Aurora Science Srl Investment ManagersFinance Aurora Science, invests in Italian startups. The fund invests in health technology with particular interest for biotech and pharmaceuticals. It provides equity financing for early stage investing between EUR 1 to EUR 5 million. | Investment Managers | Founder | |
Elanco Italia SpA
Elanco Italia SpA Pharmaceuticals: MajorHealth Technology Elanco Italia SpA operates as a global health company. It provides products, services and knowledge to prevent and treat farmed and companion animal diseases in more than 90 countries. The company is headquartered in Sesto Fiorentino, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PHILOGEN S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz SpA
Sandoz SpA Pharmaceuticals: MajorHealth Technology Sandoz SpA manufactures pharmaceutical products. It develops and distributes medicines for cardiovascular systems, antibiotics, antidepressants, anti-asthmatics, calcium compounds, and laxatives. The company is headquartered in Origgio, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Farmacéutica SA | Chairman | ||
Novartis UK Ltd.
Novartis UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis UK Ltd. is an international pharmaceutical company. It strives to discover ways to improve and extend people’s lives. The company is headquartered in Frimley, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Zambon SpA
Zambon SpA Pharmaceuticals: MajorHealth Technology Zambon SpA is engaged in manufacturing pharmaceutical products. It offers anauran, anaurette, asacol, codex, fluimucil, and giason. The company is headquartered in Bresso, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Milan | College/University | Undergraduate Degree | |
RECORDATI | Pharmaceuticals: Major | Director/Board Member | |
Ulrich Jüstrich Holding AG
Ulrich Jüstrich Holding AG Investment ManagersFinance Ulrich Jüstrich Holding AG is an investment holding private company based in Walzenhausen, Switzerland. and has subsidiaries in Switzerland and France. The Swiss company operates as an investment holding company. | Investment Managers | Director/Board Member | |
Helvecura Cooperative Society | Director/Board Member | ||
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
RUBIUS THERAPEUTICS | Biotechnology | Chairman | |
Woolsey Pharmaceuticals, Inc.
Woolsey Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Woolsey Pharmaceuticals, Inc. operates as a single-drug entity. It is focused on the treatment of rare, neurodegenerative diseases with its compound BRAVYL (Fasudil). The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz AG
Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The company is based in Basel, Switzerland. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Remedii LLC | Corporate Officer/Principal | ||
AXCA HEALPAR | Biotechnology | Chairman | |
EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman | |
Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Diagnostic Hybrids, Inc.
Diagnostic Hybrids, Inc. Medical SpecialtiesHealth Technology Diagnostic Hybrids, Inc. develops, manufactures and markets cellular and molecular diagnostic kits. Its products include rapid diagnostics, thyroid testing solutions, respiratory family testing, herpes family testing, chlamydia testing, enterovirus testing, cell lines and media and supplements. The company was founded by Wilfred R. Konneker, Joseph Jollick and Thomas E. Wagner in 1983 and is headquartered in Athens, OH. | Medical Specialties | Director/Board Member | |
INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member |
Statistieken
Internationaal
Zwitserland | 19 |
Verenigde Staten | 14 |
Italië | 14 |
Finland | 2 |
Noorwegen | 2 |
Sectoraal
Health Technology | 27 |
Consumer Services | 4 |
Commercial Services | 4 |
Finance | 4 |
Health Services | 2 |
Operationeel
Director/Board Member | 50 |
Chairman | 14 |
Chief Executive Officer | 9 |
Independent Dir/Board Member | 9 |
Corporate Officer/Principal | 9 |
Sterkste connecties
Insiders | |
---|---|
David Epstein | 29 |
Silvio Inderbitzin | 25 |
Guido Guidi | 17 |
Robert Karsunky | 4 |
Karen Chu | 4 |
Dirk Weber | 2 |
Freddy Radtke | 1 |
Michael Bauer | 1 |
Rajwinder Lehal | 1 |
- Beurs
- Insiders
- Richard Peck
- Bedrijfsconnecties